April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Laboratories’ (CNL) Nuclear Research and Test Establishment Operating License for the Chalk River Laboratories (CRL) site.
-
-
February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took steps to ensure a stable and secure supply of a critical radioactive imaging tracer used to detect potentially life-threatening diseases.
-
September 9, 2016 — The Alzheimer’s Disease Neuroimaging Initiative (ADNI) recently launched into its next phase, ADNI3, thanks to a $40 million, five-year award from the National Institutes of Health (NIH).
-
September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) e-published a new position statement supporting myocardial perfusion...
-
The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years, but molecular imaging is bringing researchers closer to identifying them, according to a new study.
Image courtesy of MR Solutions.
News | PET-MRI | May 23, 2019
May 23, 2019 — Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron...
News | Radiopharmaceuticals and Tracers | May 17, 2019
May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b...
News | Radiopharmaceuticals and Tracers | May 13, 2019
May 13, 2019 — Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F))...
Image courtesy of Amen Clinics
News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor
May 10, 2019 — Shine Medical Technologies Inc. broke ground on their first...
Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory
News | Radiopharmaceuticals and Tracers | March 14, 2019
March 14, 2019 — A team of researchers at the University of Washington announced they developed a new automated...
News | Radiopharmaceuticals and Tracers | January 30, 2019
January 30, 2019 - ImaginAb Inc. announced the enrollment of the first patient in the Phase II...
Technology | Nuclear Imaging | January 16, 2019
January 16, 2019 — MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...
MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri
News | Radiopharmaceuticals and Tracers | November 13, 2018
November 13, 2018 — The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-...
News | Nuclear Imaging | November 07, 2018
November 7, 2018 — With the recent announcement by Novartis to acquire Endocyte , interest from the conventional...
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) — the voice of the...
News | PET Imaging | September 05, 2018
September 5, 2018 — Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of...
Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.
News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study...
News | Prostate Cancer | June 13, 2018
June 13, 2018 — A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine...
Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea
News | PET Imaging | May 17, 2018
May 17, 2018 — A novel positron emission...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics Acquires Worldwide Rights to Investigational Radiohybrid PSMA-Targeted Agents
May 9, 2018 — Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a...
News | Radiopharmaceuticals and Tracers | May 03, 2018
May 3, 2018 — BWX Technologies Inc. signed a definitive agreement to acquire Sotera Health’s Nordion...
Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland
News | PET Imaging | April 10, 2018
April 10, 2018 — Researchers have developed a new imaging agent that could help guide and assess treatments for...
The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.
Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear...
News | PET Imaging | February 21, 2018
February 21, 2018 — Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the...
Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.
Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently...
